These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 3385641

  • 1. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
    Hoffmann IS, Talmaciu RK, Ferro CP, Cubeddu LX.
    J Pharmacol Exp Ther; 1988 Jun; 245(3):761-72. PubMed ID: 3385641
    [Abstract] [Full Text] [Related]

  • 2. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H, Lovenberg T, Cubeddu LX.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dopamine autoreceptors modulate dopamine release from the prefrontal cortex.
    Talmaciu RK, Hoffmann IS, Cubeddu LX.
    J Neurochem; 1986 Sep; 47(3):865-70. PubMed ID: 3734802
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of phorbol ester on prefrontal cortex and striatal dopamine terminals: dependence on rate and duration of stimulation.
    Talmaciu RK, Hoffmann IS, Cubeddu LX.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1160-5. PubMed ID: 2557413
    [Abstract] [Full Text] [Related]

  • 6. Phorbol esters and D2-dopamine receptors.
    Cubeddu LX, Lovenberg TW, Hoffman IS, Talmaciu RK.
    J Pharmacol Exp Ther; 1989 Nov; 251(2):687-93. PubMed ID: 2530340
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
    Nowak JZ, Arbilla S, Galzin AM, Langer SZ.
    J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
    [Abstract] [Full Text] [Related]

  • 9. Amphetamine inhibits the electrically evoked release of [3H]dopamine from slices of the rabbit caudate.
    Kamal LA, Arbilla S, Galzin AM, Langer SZ.
    J Pharmacol Exp Ther; 1983 Nov; 227(2):446-58. PubMed ID: 6631724
    [Abstract] [Full Text] [Related]

  • 10. Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors.
    Dwoskin LP, Zahniser NR.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):442-53. PubMed ID: 3772803
    [Abstract] [Full Text] [Related]

  • 11. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM, Cubeddu LX.
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [Abstract] [Full Text] [Related]

  • 12. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
    Faggin BM, Zubieta JK, Rezvani AH, Cubeddu LX.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224
    [Abstract] [Full Text] [Related]

  • 13. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Feb; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 14. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
    Parker EM, Cubeddu LX.
    J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738
    [Abstract] [Full Text] [Related]

  • 15. Evidence for autoreceptor modulation of endogenous dopamine release from rabbit caudate nucleus in vitro.
    Parker EM, Cubeddu LX.
    J Pharmacol Exp Ther; 1985 Feb; 232(2):492-500. PubMed ID: 3155797
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization.
    Godbout R, Mantz J, Pirot S, Glowinski J, Thierry AM.
    J Pharmacol Exp Ther; 1991 Aug; 258(2):728-38. PubMed ID: 1865369
    [Abstract] [Full Text] [Related]

  • 17. Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices.
    Wolf ME, Galloway MP, Roth RH.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):699-707. PubMed ID: 2869140
    [Abstract] [Full Text] [Related]

  • 18. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
    Snyder GL, Keller RW, Zigmond MJ.
    J Pharmacol Exp Ther; 1990 May; 253(2):867-76. PubMed ID: 2110978
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR, Bunney BS.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893
    [Abstract] [Full Text] [Related]

  • 20. Is the release of dopamine from medial prefrontal cortex modulated by presynaptic receptors? Comparison with nigrostriatal and mesolimbic terminals.
    Cubeddu LX, Hoffmann IS, Talmaciu RK.
    Ann N Y Acad Sci; 1990 Mar; 604():452-61. PubMed ID: 2171402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.